Clinical trial
a Non-randomized, Prospective, Open-label Registry to Compare the Effectiveness and Safety of XIENCE Skypoint™ Stents Versus Other DESs in Patients With Coronary Artery Disease
NCT05981911 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- a Non-randomized, Prospective, Open-label Registry to Compare the Effectiveness and Safety of XIENCE Skypoint™ Stents Versus Other DESs in Patients With Coronary Artery Disease
- Lead sponsor
- Seung-Jung Park
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 14, 2023
- Completion date
- December 31, 2026
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.